Clinical trial
Efficacy and Safety of Inhaled Insulin Compared to Metformin and Glimepiride in…
NCT00469586 · Novo Nordisk A/S, Industry · Terminated
Key facts
| NCT number | NCT00469586 |
|---|---|
| Title | Efficacy and Safety of Inhaled Insulin Compared to Metformin and Glimepiride in Type 2 Diabetes |
| Official title | Efficacy and Safety of Inhaled Prandial Insulin Compared to Metformin Plus Glimepiride in Type 2 Diabetes |
| Acronym | iINHALE 7 |
| Lead sponsor | Novo Nordisk A/S, Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diabetes, Diabetes Mellitus, Type 2 |
| Intervention type | Drug |
| Interventions | inhaled human insulin, metformin, glimepiride |
| Enrollment | 174 |
| Start date | Apr 26, 2007 |
| Primary completion | Apr 24, 2008 |
| Completion | Apr 24, 2008 |
| First posted | May 4, 2007 |
| Last update posted | Mar 1, 2017 |
| Countries | Argentina, Austria, Belgium, Bulgaria, Canada, France, India, Israel, Mexico, Poland, Turkey (Türkiye) |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: